Target Name: MIR34A
NCBI ID: G407040
Review Report on MIR34A Target / Biomarker Content of Review Report on MIR34A Target / Biomarker
MIR34A
Other Name(s): MicroRNA 34a | mir-34 | hsa-mir-34a | mir-34a | MIRN34A | miRNA34A | hsa-miR-34a-3p | hsa-miR-34a-5p | microRNA 34a

miRNA-34a: A Non-Coding RNA Molecule with Multiple Functions in The Human Body

MicroRNA 34a (miRNA-34a) is a non-coding RNA molecule that plays a crucial role in various biological processes in the human body. It is a key regulator of gene expression and has been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the unique features of miRNA-34a is its ability to interact with other molecules in the cell to control gene expression. This interaction is mediated by a protein called miRNA-like interacting protein 1 (MLIP-1), which is also a key regulator of gene expression. miRNA-34a and MLIP-1 have been shown to work together in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.

miRNA-34a has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of cancer. For example, studies have shown that miRNA-34a can inhibit the activity of the oncogene transforming growth factor beta (TGF-β), which is a key regulator of cell growth and has been implicated in the development of many types of cancer.

In addition to its role in cancer, miRNA-34a has also been shown to be involved in the regulation of a wide range of other cellular processes, including cell migration, axon guidance, and synaptic plasticity. It has been shown to play a role in the regulation of neural stem cell proliferation and has been implicated in the development of neurodegenerative diseases.

The use of miRNA-34a as a drug target or biomarker has the potential to lead to new treatments for a wide range of diseases. For example, studies have shown that inhibiting miRNA-34a activity can be an effective way to treat various types of cancer, including breast, ovarian, and colorectal cancers. In addition, miRNA-34a has also been shown to be involved in the regulation of inflammation, which has led to the potential use of miRNA-34a as an anti-inflammatory drug.

Another promising aspect of miRNA-34a is its ability to act as a biomarker for certain types of cancer. For example, studies have shown that miRNA-34a levels can be used as a biomarker for the detection and prognosis of pancreatic cancer. In addition, miRNA-34a has also been shown to be involved in the regulation of stem cell proliferation, which has led to the potential use of miRNA-34a as a biomarker for the detection and treatment of stem cell diseases.

In conclusion, miRNA-34a is a non-coding RNA molecule that plays a crucial role in various biological processes in the human body. Its ability to interact with other molecules and regulate gene expression makes it an attractive target for drug development and research into the underlying causes of a wide range of diseases. Further studies are needed to fully understand the role of miRNA-34a in cellular processes and its potential as a drug target or biomarker.

Protein Name: MicroRNA 34a

The "MIR34A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR34A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR34AHG | MIR34B | MIR34C | MIR3529 | MIR3591 | MIR3605 | MIR3606 | MIR3609 | MIR361 | MIR3610 | MIR3611 | MIR3612 | MIR3613 | MIR3614 | MIR3615 | MIR3616 | MIR3617 | MIR3618 | MIR3619 | MIR362 | MIR3620 | MIR3621 | MIR3622A | MIR3622B | MIR363 | MIR3646 | MIR3648-1 | MIR3649 | MIR3650 | MIR3651 | MIR3652 | MIR3654 | MIR3655 | MIR3658 | MIR3659 | MIR365A | MIR365B | MIR3660 | MIR3661 | MIR3662 | MIR3663 | MIR3664 | MIR3665 | MIR3667 | MIR3667HG | MIR3668 | MIR367 | MIR3670-1 | MIR3670-2 | MIR3671 | MIR3672 | MIR3674 | MIR3675 | MIR3677 | MIR3678 | MIR3679 | MIR3680-1 | MIR3680-2 | MIR3681 | MIR3681HG | MIR3682 | MIR3683 | MIR3685 | MIR3686 | MIR3687 | MIR3688-1 | MIR3688-2 | MIR3689A | MIR3689B | MIR3689C | MIR3689D1 | MIR3689D2 | MIR3689F | MIR369 | MIR3690 | MIR3691 | MIR3692 | MIR370 | MIR3713 | MIR3714 | MIR371A | MIR371B | MIR372 | MIR373 | MIR374A | MIR374B | MIR374C | MIR375 | MIR376A1 | MIR376A2 | MIR376B | MIR376C | MIR377 | MIR378A | MIR378B | MIR378C | MIR378D1 | MIR378D2 | MIR378E | MIR378F